Mobile

Double blind placebo controlled clinical investigation into the efficacy and tolerability of inhaled treprostinil in patients with severe pulmonary arterial hypertension

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-003236-59

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the effects of chronically administered, inhaled Treprostinil Sodium (TRE) on exercise capacity with an un-encouraged 6-minute walk test (6MWT) in patients with pulmonary arterial hypertension (PAH).

Critère d'inclusion

  • NYHA Class III and IV patients with severe Pulmonary Arterial Hypertension (PAH)

Liens